Following cytotoxicity assays using breast cancer MCF-7 cells revealed that CPT2 offered a similar cytotoxicity (62% reduced cell proliferation) to free CPT (68%), while toxicity of CPT1 was significantly lower (39%). The gene discussed is CPT2; the disease is breast cancer.